Skip to Navigation
Calderdale and Huddersfield NHS Foundation Trust
West Yorkshire and Harrogate, Cancer Alliance
Time period: 2015-19
|
Cancer Alliance |
|
National |
| Number of High Grade Dysplasia patients in audit |
28 |
|
1448 |
|
Cancer Alliance |
|
National |
| Method of Diagnosis |
| – First diagnosis confirmed by second pathologist |
22 |
76.9% |
86.9% |
| Treatment planning |
| – HGD plan discussed at MDT |
25 |
89.3% |
87.9% |
| – Treatment plan for active treatment |
23 |
82.1% |
81.1% |
| First treatment |
| – Endoscopic therapy (such as endoscopic resection) |
23 |
82.1% |
73.8% |
| – Surveillance |
3 |
10.7% |
11.0% |
Time period: 2017-2019
|
Organisation |
|
National |
| Number of oesophago-gastric (OG) cancer patients in audit |
176 |
|
20528 |
| Case ascertainment for OG cancer (%) |
85-100% |
|
|
| Method of Diagnosis |
– Patients diagnosed after an emergency admission**
** Percent figure accounts for differences in mix of patients across organisations |
33 |
18.9% |
13.3% |
| – Patients with referral source reported as unknown |
8 |
4.5% |
1.8% |
| Pre-treatment staging of cancer |
| – Patients having staging CT scan recorded |
170 |
96.6% |
86.9% |
| Treatment planning |
| – Patients having a plan for curative treatment |
48 |
27.3% |
38.5% |
| – Patients having a plan for non-curative treatment |
128 |
72.7% |
61.5% |
| – Patients with non-curative plans having chemotherapy or radiotherapy |
41 |
32.0% |
48.2% |
Download this data as a PDF
Copyright © 2021 National Oesophago-Gastric Cancer Audit | Lovingly Crafted by
Mixd